HR Execs on the Move

PharmScript

www.pharmscript.com

 
At PharmScript, we are healthcare professionals first. Together, we believe in the power of helping our clients deliver true patient-centered care.
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details
kimberly warnecke
Chief People Officer Profile
Carrie Sorrells
Sr Director HR Operations and Total Rewards Profile
Heather Cullen
Chief Human Resources Officer Profile

Similar Companies

Medical Laboratory Diagnostics

Find local doctors and healthcare providers near you. See their ratings, reviews, contact info, address, profile, and more.

Concept Matrix Solutions

Concept Matrix Solutions is a company that specializes in the formulation, development, and manufacturing of novel drug delivery systems utilizing CBD from Industrial Hemp and other cannabinoids, as well as Nutraceuticals. They also provide the highest...

SERVICES Hospital Pharmacy Management and Consulting

SERVICES Hospital Pharmacy Management & Consulting is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KCR

KCR is a clinical development solutions provider for the biotechnology, pharmaceutical, and medical device industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people.

Olema

Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.